News & Updates
Showing Multidisciplinary articles
Showing

Avelumab benefit may extend to cisplatin-unfit bladder cancer patients
The anti-PD-L1 antibody avelumab demonstrated clinical activity as first-line treatment for patients with metastatic or locally advanced urothelial carcinoma who were PD-L1-positive and ineligible for cisplatin, according to findings from the ARIES trial presented at EAU 2022.

What do young T1DM patients look for in ketone breath sensors?
Young patients with type 1 diabetes mellitus (T1DM) find the noninvasive nature of ketone breath sensor devices attractive, especially as compared with blood testing, according to a recent study. Still, concerns about such devices remain, including their ease of use, accuracy, and affordability.

Myocardial infarction after GI bleeding ups in-hospital mortality, resource use
A diagnosis of type 1 or type 2 myocardial infarction (MI) following hospitalization for gastrointestinal bleeding (GIB) often leads to higher in-hospital mortality and resource utilization, results of a recent US study have shown.






